Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 4 1Phase 3 1Phase 2 1

Status

Completed 6Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 6OTHER 2

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Dermatologic 3Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Keratosis, Actinic 3Keratosis 2Precancerous Conditions 1Neoplasms 1Lymphoma 1Leukemia, Myeloid, Acute 1Bone-Metastatic, Castration-Resistant Prostate Cancer 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × INDUSTRY × tirbanibulin × Clear all
NCT06135415 2026-03-25

TirbAKare

Almirall, S.A.

Phase 3 Completed
280 enrolled
DermatologicOther neoplasm

Keratosis, Neoplasms, Precancerous Conditions, Keratosis, Actinic

NCT05741294 2025-02-20

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Almirall, S.A.

Phase 4 Completed
334 enrolled 12 charts
Dermatologic

Keratosis, Keratosis, Actinic

NCT05260073 2024-09-20

PROAK

Almirall, S.A.

Completed
300 enrolled 9 charts
Dermatologic

Keratosis, Actinic

NCT01074138 2023-02-02

Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer

Athenex, Inc.

Phase 2 Completed
31 enrolled
Genitourinary

Bone-Metastatic, Castration-Resistant Prostate Cancer

NCT01397799 2015-12-07

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

Athenex, Inc.

Phase 1 Completed
24 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00658970 2011-06-08

Evaluation of KX2-391 in Patients With Advanced Malignancies

Athenex, Inc.

Phase 1 Completed
50 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡